Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination extract of **Chenopodium formosanum** (Djulis) and **Fagopyrum esculentum** (buckwheat) contains bioactive phytochemicals known for antioxidant, anti-inflammatory, hepatoprotective, anti-hyperglycemic, and potential anti-tumor effects. - **Chenopodium formosanum extract** is rich in polyphenols, flavonoids, and betalain pigments, demonstrating strong antioxidant activity, hepatoprotection (by modulating cytokines and antioxidant enzymes), inhibition of inflammatory pathways such as TLR4/NF-κB, and reduction in hyperglycemia and hyperlipidemia. - **Fagopyrum esculentum extract** (from seeds, leaves, or sprouts) contains significant levels of rutin and other flavonoids, offering anti-inflammatory, antioxidant, anti-hyperglycemic, and potential anti-tumor activities. It is used in traditional medicine for invigorating the spleen and combating inflammation, detoxification, and fever. No evidence indicates an established pharmaceutical product formed by combining both extracts, but both ingredients are well-studied as dietary supplements or nutraceuticals with overlapping mechanisms, including free radical scavenging, cytokine modulation, and metabolic support[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chenopodium formosanum extract + fagopyrum esculentum extract.